title: HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction.
abstract: The intrinsic immunity factor CD317 (BST-2/HM1.24/tetherin) imposes a barrier to HIV-1 release at the cell surface that can be overcome by the viral protein Vpu. Expression of Vpu results in a reduction of CD317 surface levels; however, the mechanism of this Vpu activity and its contribution to the virological antagonism are incompletely understood. Here, we characterized the influence of Vpu on major CD317 trafficking pathways using quantitative antibody-based endocytosis and recycling assays as well as a microinjection/microscopy-based kinetic de novo expression approach. We report that HIV-1 Vpu inhibited both the anterograde transport of newly synthesized CD317 and the recycling of CD317 to the cell surface, while the kinetics of CD317 endocytosis remained unaffected. Vpu trapped trafficking CD317 molecules at the trans-Golgi network, where the two molecules colocalized. The subversion of both CD317 transport pathways was dependent on the highly conserved diserine S52/S56 motif of Vpu; however, it did not require recruitment of the diserine motif interactor and substrate adaptor of the SCF-E3 ubiquitin ligase complex, β-TrCP. Treatment of cells with the malaria drug primaquine resulted in a CD317 trafficking defect that mirrored that induced by Vpu. Importantly, primaquine could functionally replace Vpu as a CD317 antagonist and rescue HIV-1 particle release.
  
  
  OBJECTIVE
  HIV efficiently replicates in the human host and induces the life-threatening immunodeficiency AIDS. Mammalian genomes encode proteins such as CD317 that can inhibit viral replication at the cellular level. As a countermeasure, HIV has evolved genes like vpu that can antagonize these intrinsic immunity factors. Investigating the mechanism by which Vpu overcomes the virion release restriction imposed by CD317, we find that Vpu subverts recycling and anterograde trafficking pathways of CD317, resulting in surface levels of the restriction factor insufficient to block HIV-1 spread. This describes a novel mechanism of immune evasion by HIV.
authors: Department of Infectious Diseases, Virology, University of Heidelberg, Heidelberg, Germany.
authors: Sarah
authors: S
authors: Schmidt
authors: Joëlle V
authors: JV
authors: Fritz
authors: Julia
authors: J
authors: Bitzegeio
authors: Oliver T
authors: OT
authors: Fackler
authors: Oliver T
authors: OT
authors: Keppler
references: J Virol. 2010 Apr;84(8):4089-94
references: 20147395
references: J Virol. 2010 Dec;84(24):12958-70
references: 20926557
references: PLoS Pathog. 2010 Jun 17;6(6):e1000955
references: 20585562
references: J Cell Biol. 2000 Dec 11;151(6):1281-94
references: 11121442
references: Retrovirology. 2010 Jan 15;7:1
references: 20078884
references: PLoS Pathog. 2010 Apr 08;6(4):e1000856
references: 20386718
references: J Virol. 2010 Oct;84(20):10569-80
references: 20686043
references: J Virol. 2009 Mar;83(5):2382-5
references: 19091864
references: J Biol Chem. 2011 Jan 28;286(4):2987-97
references: 21084286
references: Cell Host Microbe. 2008 Apr 17;3(4):245-52
references: 18342597
references: J Virol. 2011 Mar;85(6):2611-9
references: 21191020
references: Traffic. 2003 Oct;4(10):694-709
references: 12956872
references: J Virol. 2010 Dec;84(23):12185-99
references: 20861257
references: J Biol Chem. 2009 Jun 5;284(23):15927-41
references: 19359243
references: Retrovirology. 2011 Feb 10;8:9
references: 21310048
references: J Virol. 2010 Nov;84(21):11374-84
references: 20702620
references: Retrovirology. 2010 Dec 22;7:114
references: 21176220
references: Eur J Cell Biol. 2000 Jun;79(6):394-9
references: 10928454
references: Cell Host Microbe. 2010 Apr 22;7(4):314-323
references: 20399176
references: Cell Host Microbe. 2008 Jun 12;3(6):388-98
references: 18541215
references: Virology. 1995 Nov 10;213(2):639-49
references: 7491787
references: J Virol. 2009 Aug;83(15):7536-46
references: 19474106
references: PLoS Pathog. 2010 Apr 29;6(4):e1000869
references: 20442859
references: J Virol. 1992 Jan;66(1):226-34
references: 1727486
references: J Biol Chem. 2009 Dec 11;284(50):35060-72
references: 19837671
references: Curr Top Microbiol Immunol. 2009;339:47-66
references: 20012523
references: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2886-91
references: 19179289
references: Mol Cell. 1998 Mar;1(4):565-74
references: 9660940
references: PLoS Pathog. 2009 Sep;5(9):e1000574
references: 19730691
references: J Biol Chem. 1991 Oct 25;266(30):20323-8
references: 1657920
references: Mol Cell. 1999 Jun;3(6):729-39
references: 10394361
references: J Virol. 2006 Aug;80(16):8047-59
references: 16873261
references: Cell. 2002 Dec 13;111(6):853-66
references: 12526811
references: J Virol. 2010 May;84(9):4646-58
references: 20147389
references: Retrovirology. 2010 Jun 07;7:51
references: 20529266
references: Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):17951-6
references: 20880831
references: Traffic. 2006 Mar;7(3):298-307
references: 16497224
references: J Virol. 2009 May;83(9):4574-90
references: 19244337
references: J Virol. 2011 Jan;85(2):932-45
references: 21068238
references: Methods Enzymol. 2009;460:357-77
references: 19446735
references: J Virol. 2009 Oct;83(19):9672-81
references: 19605472
references: J Virol. 2009 Aug;83(16):7931-47
references: 19515779
references: Commun Integr Biol. 2010 Jul;3(4):366-9
references: 20798829
references: J Virol. 2007 Feb;81(3):1502-5
references: 17121803
references: J Virol. 2009 Feb;83(4):1837-44
references: 19036818
references: EMBO J. 1992 Mar;11(3):863-74
references: 1532143
references: J Biol Chem. 2006 Nov 10;281(45):34574-91
references: 16935861
references: Nature. 2008 Jan 24;451(7177):425-30
references: 18200009
references: J Neuroimmune Pharmacol. 2011 Jun;6(2):188-201
references: 21222046
references: PLoS Pathog. 2006 Oct;2(10):e107
references: 17238276
references: PLoS Pathog. 2010 Apr 15;6(4):e1000843
references: 20419159
references: Retrovirology. 2010 Dec 24;7:115
references: 21184674
references: Cell Host Microbe. 2009 Mar 19;5(3):285-97
references: 19286137
references: Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18428-32
references: 20940320
references: Retrovirology. 2007 Oct 15;4:75
references: 17937819
references: Nature. 1990 Aug 16;346(6285):655-7
references: 2166918
references: J Virol. 2010 Dec;84(24):12646-57
references: 20943977
references: Cell. 2008 Dec 26;135(7):1175-87
references: 19109890
references: Cell. 2009 Oct 30;139(3):499-511
references: 19879838
references: J Cell Sci. 2007 Nov 1;120(Pt 21):3850-8
references: 17940069
references: PLoS Pathog. 2009 May;5(5):e1000443
references: 19461879
references: FEBS Lett. 2009 Dec 3;583(23):3811-6
references: 19879268
references: Proc Natl Acad Sci U S A. 2009 Feb 24;106(8):2868-73
references: 19196977
references: J Cell Sci. 2010 Sep 15;123(Pt 18):3071-83
references: 20736309
references: Biochem Biophys Res Commun. 1999 May 19;258(3):583-91
references: 10329429
references: J Cell Biol. 2000 Jul 24;150(2):377-89
references: 10908579
references: PLoS Pathog. 2009 May;5(5):e1000450
references: 19478868
references: EMBO J. 2004 Jul 7;23(13):2531-43
references: 15192707